BOL-DP-o-08 / BOL Pharma - LARVOL DELTA

A Study to Evaluate the Safety and Efficacy of BOL-DP-o-08 in Patients With Endometriosis Syndrome. (clinicaltrials.gov) - P2a | N=0 | Withdrawn | Sponsor: Breath of Life International Pharma Ltd | N=80 ➔ 0 | Not yet recruiting ➔ Withdrawn

Enrollment change • Trial withdrawal • Endometriosis • Gynecology • Women's Health

A Study to Evaluate the Safety and Efficacy of BOL-DP-o-08 in Patients With Endometriosis Syndrome. (clinicaltrials.gov) - P2a; N=80; Not yet recruiting; Sponsor: Breath of Life International Pharma Ltd; Trial completion date: Jul 2021 ➔ Apr 2023; Trial primary completion date: Jul 2021 ➔ Mar 2023

Clinical • Trial completion date • Trial primary completion date • Endometriosis • Gynecology